CML-RAE-1γ-Dex effectively enhanced the proliferation and effector functions of NK cells, CD4+ T cells and CD8+ T cells, which in turn produced strong anti-CML efficacy in vitro. This evidence concerns the gene CD8A and chronic myelogenous leukemia, BCR-ABL1 positive.